Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer.

Doshi, Sahil D; DeStephano, David; Accordino, Melissa K; Elkin, Elena; Raghunathan, Rohit R; Wright, Jason D; Hershman, Dawn L

Doshi, Sahil D; DeStephano, David; Accordino, Melissa K; Elkin, Elena; Raghunathan, Rohit R; Wright, Jason D; Hershman, Dawn L.

Afiliação

Doshi SD; Division of Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. doshis@mskcc.org.
DeStephano D; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Accordino MK; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Elkin E; Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Raghunathan RR; Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.
Wright JD; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.

Breast Cancer Res Treat ; 203(1): 111-119, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37688666

Assuntos

Neoplasias da Mama; Vacinas contra Influenza; Humanos; Feminino; Idoso; Estados Unidos/epidemiologia; Neoplasias da Mama/patologia; Estudos Retrospectivos; Medicare; Sobreviventes

Palavras-chave

Influenza vaccine; Metastatic breast cancer; Primary care; SEER-Medicare; Survivorship

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Vacinas contra Influenza Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Female / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google